A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor
| Image |  |
|---|---|
| Description | scientific article published on 03 October 2019 |
| Author/s |
author: Sofia Moco |
| Publication date | October 3, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |